RTX A/S
Noerresundby, Denmark, 19 March 2021
Announcement no. 20/2021
The Board of Directors of RTX has, cf. company announcement no. 38 dated 25. November 2020, resolved to initiate a share buy-back programme in accordance with the provisions of Article 5 Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 (MAR) and the Commission’s delegated Regulation (EU) 2016/1052 of 8 March 2016, also referred to as the "Safe Harbor" rules.
Under the programme RTX will buy back shares for an amount up to DKK 50 million and no more than 500,000 shares in the period from 25 November 2020 to 30 September 2021.
The following transactions have been made under the programme in the period from 12 March 2021 to 18 March 2021:
| Number of shares | Average purchase price | Transaction value in DKK | |
| Accumulated, latest announcement | 134,000 | 206.21 | 27,632,006 |
| 12 March 2021 | 1,500 | 188.91 | 283,365 |
| 15 March 2021 | 1,400 | 190.99 | 267,386 |
| 16 March 2021 | 1,400 | 193.80 | 271,320 |
| 17 March 2021 | 1,400 | 191.93 | 268,702 |
| 18 March 2021 | 1,300 | 187.83 | 244,179 |
| Accumulated under the programme | 141,000 | 205.44 | 28,966,958 |
With the transactions stated above, RTX A/S owns a total of 386,386 of treasury shares, corresponding to 4.47% of the share capital. The total number of shares in the company is 8,642,838 including treasury shares.
In accordance with the Regulation (EU) No. 596/2014, transactions related to the share buy-back programme are presented in detailed form in the appendix attached to this company announcement.
Enquiries and further information:
CEO Peter Røpke, tel +45 96 32 23 00
RTX’s homepage: www.rtx.dk
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Santhera Pharmaceuticals Holding AG8.1.2026 08:16:03 CET | Press release
Santhera Licenses AGAMREE® (Vamorolone) to Nxera Pharma in Japan, South Korea, Australia and New Zealand in a Deal Valued at up to USD 205 Million Plus Royalties
CMR Surgical8.1.2026 08:03:26 CET | Press release
CMR Surgical receives CE Mark for use of Versius in paediatric surgery
Sampo plc8.1.2026 07:30:00 CET | Press release
Sampo plc’s share buybacks 7 January 2026
Basilea Pharmaceutica AG, Allschwil8.1.2026 07:15:00 CET | Press release
Basilea provides portfolio update and outlook
Sodexo SA8.1.2026 07:00:00 CET | Press release
Sodexo Q1 Fiscal 2026 revenues in line with expectations
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
